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Abstract: One of the most prevalent cancers in children and adults, acute leukemia has the
potential to lead to death if left untreated. Within a few weeks after diagnosis, childhood
ALL has spread throughout the body, posing a serious health risk to the patient. Evaluation
of acute leukemia contains uncertainty and incomplete information. Due to the subjective
nature of the expectations, this rating procedure incorporates ambiguity and inaccuracy. To
illustrate the ambiguity of our subjective judgments, we can use the triplet T, F, and I, truth,
falsity, and indeterminacy (I). Therefore, a Single-Valued Neutrosophic Sets (SVNSs)
approach based on AHP, TOPSIS, and VIKOR is designed and implemented in this article.
Neutrosophic AHP is used to determine the weighting of criteria in this methodology. A
neutrosophic TOPSIS and VIKOR model are used to rank alternatives. There is further
validation and verification of the proposed methodology in the application. To demonstrate
the adaptability of the offered decisions under various circumstances, sensitivity
assessments and comparative analyses were carried out.
Keywords: AHP; TOPSIS; VIKOR; Acute Leukemia; Neutrosophic; MCDM
________________________________________________________________________________
1. Introduction and Background
There are a wide variety of blood-related diseases known as acute leukemia, which are
defined by aberrant growth of blast cells in bone marrow, which results in the replacement
of healthy cells and a decrease in the 3 hematopoietic types in peripheral blood.
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Approximately 300,000 people are expected to die from them in 2018, making them the 11th
and 10th greatest common causes of cancer in the world, respectively. There are 3.7 new
cases of acute myeloid leukemia per 100,000 residents in Europe each year, with only 19
percent of those patients surviving for five years[1]. A precise and appropriate diagnosis is
essential to successful disease control. In the bone marrow, immature lymphocytes cause
acute lymphoblastic leukemia (ALL), also known as acute lymphocytic leukemia [2], [3].
Upon entering the bloodstream, leukemic cells move rapidly to several organs and tissues,
including the spleen, liver, lymph nodes, brain, and the neurological system. The bone
marrow and blood are primarily affected by ALL, which is a disease of the immune system
[4], [5]. It is also known as acute pediatric leukemia because it is the most prevalent kind of
leukemia in children since chronic and myeloid leukemias are rare in children.
For an accurate diagnosis of acute leukemia, the World Health Organization (WHO)
recommends combining morphology with additional tests like immunophenotype,
cytogenetics, and molecular biology[6]. As a result, finding blasts in the blood is still the first
step in their diagnosis. It is true that smear review takes a long time, requires well-trained
staff, and is subject to base on inter variability, which is especially important when dealing
with the blast. Indeed, leukemia types have small interclass morphological variations, which
results in low specificity scores during routine screening[7]. There's little doubt that clinical
pathologists have difficulty distinguishing between different types of blasts and the
subjective nature of their morphological identification. Leukemia lineage identification is
critical since the prognosis and acute treatment effects are heavily dependent on this
differentiation. Although automated blood cell image analyzers tend to underestimate the
amount of blast cells, this complex topic hasn't been addressed in the literature[8], [9].
Medical diagnosis has been refrained by statistical approaches, pattern recognition,
artificial intelligence, and neural networks[10]–[14]. To make medical diagnoses easier,
another tool called a "MCDA" was developed. The MCDA approach uses the preference
relational system proposed by Roy in 1996 [15] and Vincke in 1992 [16] to compare the
individuals to be categorized and prototypes (prototypes are the reference points of classes).
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It is so possible to use both qualitative and quantitative criteria in the MCDA approach.
Additionally, it aids in overcoming some of the challenges associated with expressing data
in several units.
In addition, several researchers provide certain improvements and enhancements to
improve acute leukemia classification performance by better representing and reflecting
acute leukemia data. Reviewing the above expansions reveals that the various types of
uncertainty in the data set are primarily to blame for these additional versions. Different
forms of fuzzy set extensions are used to address the uncertainty in the data set since it may
contain vagueness, imprecision, indeterminacy, and hesitant information. There is no
middle ground in classical set theory, optimization, and Boolean logic. An element can
either belong to a set or not, and a statement can only be true or false[17]. The problem is
that in the real world, hardly anything is accurate and it's all a relative term that cannot be
characterized by classical reasoning. This type of ambiguity was addressed by Zadeh's fuzzy
sets theory [18]. Since its inception in 1965, it has been reimagined in some ways. By
introducing type-2 fuzzy sets, the mathematical procedures of Zadeh were able to better
depict their imprecision [19]. A concept called "intuitional fuzzy sets" (also known as
"membership degrees") was first developed by Atanassov in 1986 [20].
Afterward, Smarandache presents neutrosophic sets that have three distinct subsets to
reflect different sorts of uncertainty [21]. Each element in the cosmos has a degree of
truthiness, indeterminacy, and falsehood between 0 and 1, and these degrees are
independent subsets of the neutrosophic sets [21]. To discriminate between degrees of
belonging and non-belongingness and to depict absoluteness from relativeness,
indeterminacy functions are used in neutrosophic sets. Neutrosophic sets use this notation
to deal with the system's uncertainty and lessen the indecision caused by conflicting data.
The neutrosophic sets have the most essential benefit over other fuzzy extensions in this
regard. Three functions of neutrosophic sets give a domain area that can be used to
undertake mathematical operations with varying degrees of uncertainty.
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Analytic Hierarchy Process (AHP), developed by Saaty [22], is a well-known technique
for solving complicated problems by breaking them down into subproblems and then
combining the solutions of these subproblems. It is critical to ensure that the judgments are
consistent in this procedure, which uses pairwise comparisons of experts. According to the
literature [23]–[32], AHP is frequently utilized as a standard procedure.
When faced with uncertainty and incomplete information, one popular decisionmaking technique is the TOPSIS approach, which allows for a wide range of alternatives
and criteria to be considered in the decision-making process [33]. Consequently, TOPSIS is
an excellent method for determining the predicted usefulness of a scenario that is
ambiguous, lacking information, or vague. Using the TOPSIS technique, it is possible to
identify a short distance from the ideal solution and a long distance from the negative-ideal
solution, but these distances are not reflected in their proportionate significance.
Serafim Opricovic (1998) first developed the VIKOR technique, which was first applied
in 2004 by Opricovic and Tzeng to solve multicriteria decision-making problems. To begin,
there is a compromise solution, which is closer to an ideal answer than any other option
available.
Many studies employ the SVNS technique. Distance measurement for SVNSs was first
proposed by ahin and Küçük [34] using the neutrosophic subset idea. Several steps in the
analysis of Ye [35] were shown to be unrealistic by Peng et al. [36]. Making decisions using
machine learning methods has recently become popular [37]. There is also a growing usage
of deep learning and other types of learning-based methodologies in the field of decisionmaking [38] in engineering research [39]–[44]. Machine learning, on the other hand, has its
drawbacks, such as the fact that it requires a distinct training phase each time and is only
applicable to the data it is trained on. The current scoring function and distance measure
utilized in many research with SVNSs yielded erroneous results, according to an analysis of
the literature. As a result of this research, we have devised a new score function and a new
distance measure.
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The remainder of this paper is structured as follows: Section 2 outlines the method that
will be taken and lays the groundwork for it. Applicability is shown in Section 3, which
includes problem definitions, computations, and results. Section 4 provides comparative
assessments and section 5 provides sensitivity analysis. Section 6 concludes with some final
thoughts and ideas for future research.
2. Methodology
By Saaty, the AHP approach was invented, which allows for comparisons between two
variables. This study proposes a single-valued neutrosophic (SVN) AHP approach.
Step 1: Build the comparison matrix between criteria as:
𝑋11
𝑋= ( ⋮
𝑋𝑎1

⋯ 𝑋1𝑏
⋱
⋮ )
⋯ 𝑋𝑎𝑏

(1)

Where 𝑎 = 1,2,3 … , 𝑒 (𝑎𝑙𝑡𝑒𝑟𝑛𝑎𝑡𝑖𝑣𝑒𝑠), 𝑏 = 1,2,3 … , 𝑓(𝑐𝑟𝑖𝑡𝑒𝑟𝑖𝑎)
Step 2: Compute the score function as:
𝑆(𝑋) =

2+𝑎−𝑏−𝑐
3

(2)

Which, a, b and c present truth, indeterminacy, and falsity values.
Step 3: Normalize the comparison matrix as:
𝑁(𝐴) =

𝐴𝑎
∑𝑒𝑎=1 𝐴𝑎

(3)

where, 𝐴𝑎 value in comparison matrix and ∑𝑒𝑎=1 𝐴𝑎 sum all values in each column.
Step 4: Compute the weights of criteria by taking the average row.
Step 5: Check the consistency ratio (CR)
Apply the Steps of the TOPSIS method
The steps of the TOPSIS approach are as follows:
A. A decision matrix should be built.
B. Make the decision-making matrix uniform.
C. Make a decision matrix that is normalised and weighted.
D. Decide on the ideal remedies for the positive and negative scenarios you're dealing
with.
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E. The ideal solutions, both positive and negative, are at a certain distance from each
alternative.
F. Distance measurements can be used to calculate the relative closeness coefficients.
G. Rank alternatives
Step 6: Build the decision matrix between criteria and alternatives as Eq. (1), then convert
the neutrosophic values to one value by Eq. (2).
Step 7: Normalize the decision matrix as:
𝑁𝑜𝑟𝑒𝑓 =

𝑋𝑒𝑓
2
√∑𝑏
𝑓=1 𝑋𝑒𝑓

(4)

Step 8: Compute the weighted normalized decision matrix as:
𝑊𝑁𝑒𝑓 = 𝑁𝑜𝑟𝑒𝑓 ∗ 𝑊𝑓

(5)

where 𝑊𝑓 the weights of the criteria
Step 9: Compute the positive and cost ideal solution as:
𝑃𝐼𝑒+ = max 𝑊𝑁𝑒𝑓 for positive criteria

(6)

𝑃𝐼𝑒− = min 𝑊𝑁𝑒𝑓 for cost criteria

(7)

𝑃𝐼𝑒− = min 𝑊𝑁𝑒𝑓 for positive criteria

(8)

𝑒

𝑒

𝑒

𝑃𝐼𝑒− = max 𝑊𝑁𝑒𝑓 for cost criteria
𝑒

(9)

Step 10: Compute the distance of each alternative from the positive and cost criteria as:
𝐷𝐼𝑓+ = √∑𝑏𝑒(𝑊𝑁𝑒𝑓 − 𝑃𝐼𝑒+ )2

(10)

𝐷𝐼𝑓− = √∑𝑏𝑒(𝑊𝑁𝑒𝑓 − 𝑃𝐼𝑒− )2

(11)

Step 11: Compute the closeness coefficient as:
𝐶𝐶𝑓 =

𝐷𝐼𝑓−
−
𝐷𝐼𝑓 +𝐷𝐼𝑓+

(12)

Step 12: Rank alternatives according to descending values of 𝐶𝐶𝑓
Apply the steps of the VIKOR method
Step 13: Compute the positive and cost ideal solution as:
𝐶𝐼𝑒+ = max 𝑋𝑒𝑓 for positive criteria
𝑒

(13)
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𝐶𝐼𝑒− = min 𝑋𝑒𝑓 for cost criteria

(14)

𝐶𝐼𝑒− = min 𝑋𝑒𝑓 for positive criteria

(15)

𝑒

𝑒

𝐶𝐼𝑒− = max 𝑋𝑒𝑓 for cost criteria

(16)

𝑒

Step 14: Compute the value of 𝐶𝑒 and 𝐷𝑒 as:
𝐶𝐼𝑒+ −𝑋𝑒𝑓

𝐶𝑒 = ∑𝑏𝑓=1 𝑊𝑓 ∗
𝐷𝑒 = max 𝑊𝑓 ∗
𝑓

(17)

𝐶𝐼𝑒+ −𝐶𝐼𝑒−
𝐶𝐼𝑒+ −𝑋𝑒𝑓

(18)

𝐶𝐼𝑒+ −𝐶𝐼𝑒−

Step 15: Compute the value of 𝐺𝑒 as:
𝐶𝑒 −min 𝐶𝑒

𝐺𝑒 = 𝑖 ∗ (max 𝐶
𝑒

𝑒

𝑒 −min 𝐶𝑒
𝑒

𝐷𝑒 −min 𝐷𝑒

) + (1 − 𝑖) ∗ (max 𝐷
𝑒

𝑒

𝐷𝑒
𝑒 −min
𝑒

)

(19)

Where the value of 𝑖 is in the range 0 to 1. It refers to the utility degree. We use the 𝑖 =0.5.
Step 16: Rank alternatives according to ascending value of 𝐺𝑒 .

3. Application
To validate the steps of the methodology, we apply them with the application. We collected
the criteria and alternatives from previous studies as in Fig 1. The decision-makers are
selected according to their experts in this field to evaluate the criteria and alternatives by
using the single-valued neutrosophic numbers (SVNNs) as [45]. Then we convert the
SVNNs into one value by applying Eq. (2) score function. This matrix is called a comparison
matrix where data between criteria. Then compute the normalized comparison matrix in
Table 1. Then compute the weights of criteria where 𝑤1 = 0.138656, 𝑤2 = 0.163386, 𝑤3 =
0.168678, 𝑤4 = 0.227536, 𝑤5 = 0.301744. According to [46] the opinions of experts are
consistent. Then go-ahead to apply the steps of the TOPSIS method.

Mona Gamal et al, Ensemble Classifiers for Acute Leukemia Classification Using Microarray Gene Expression Data under Uncertainty

Neutrosophic Sets and Systems, Vol. 49, 2022

171

Fig 1. The criteria and alternatives in this study.
Table 1. Normalized comparison matrix by the AHP method.
Criteria

𝑨𝑳𝑴𝟏

𝑨𝑳𝑴𝟐

𝑨𝑳𝑴𝟑

𝑨𝑳𝑴𝟒

𝑨𝑳𝑴𝟓

𝐴𝐿𝑀1

0.076252 0.128138 0.113528 0.242515 0.132848

𝐴𝐿𝑀2

0.186664

0.07842

𝐴𝐿𝑀3

0.16945

0.409503 0.063071 0.103204 0.098162

𝐴𝐿𝑀4

0.16945

0.19197

0.329354 0.134731 0.312175

𝐴𝐿𝑀5

0.398184

0.19197

0.445734 0.299401

0.048313

0.22015

0.283385

0.17343

Let experts build the decision matrix between criteria and alternatives. Then normalize the
decision matrix as Eq. (4) in Table 2. Then compute the weighted normalized decision matrix
as Eq. (5). All criteria are positive so, we apply Eqs. (6 and 8) to obtain a positive and cost
ideal solution. Then compute the distance of each alternative from the positive and cost ideal
solution as Eq. (10) in Table 3. Then compute the closeness coefficient as Eq. (12). Finally
rank alternatives according to the biggest value of the closeness coefficient as 𝐴𝐶𝑀3 ≻
𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀4 ≻ 𝐴𝐶𝑀2 . Fig 2. Show the rank of alternatives by the TOPSIS method.
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0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
ACM1

ACM2

ACM3

ACM4

Values
Fig 2. The rank of alternatives by the TOPSIS method.

Table 2. Normalized decision matrix by the TOPSIS method.
Criteria/alternatives

𝑨𝑳𝑴𝟏

𝑨𝑳𝑴𝟐

𝑨𝑳𝑴𝟑

𝑨𝑳𝑴𝟒

𝑨𝑳𝑴𝟓

𝐴𝐶𝑀1

0.310344828

0.166521739

0.268576544

0.461775269

0.160249151

𝐴𝐶𝑀2

0.097586207

0.355217391

0.243807819

0.145202668

0.216874292

𝐴𝐶𝑀3

0.310344828

0.123043478

0.243807819

0.196511031

0.462627407

𝐴𝐶𝑀4

0.281724138

0.355217391

0.243807819

0.196511031

0.160249151

Table 3. Distance of each alternative from positive and cost criteria.
Criteria/alternatives

𝑨𝑳𝑴𝟏

𝑨𝑳𝑴𝟐

𝑨𝑳𝑴𝟑

𝑨𝑳𝑴𝟒

𝑨𝑳𝑴𝟓

𝐴𝐶𝑀1

0

0.000950507

0

0

0.008324884

𝐴𝐶𝑀2

0.000870268

0

1.74551E-05

0.005188551

0.005498891

𝐴𝐶𝑀3

0

0.001438991

1.74551E-05

0.003642981

0

𝐴𝐶𝑀4

1.57485E-05

0

1.74551E-05

0.003642981

0.008324884

By using the decision matrix from the TOPSIS method, the VIKOR method used the Eqs. (13
and 15) to compute the positive and cost ideal solution in Table 4. Eqs. (17 and 18) are used
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to compute the values of 𝐶𝑒 , 𝐷𝑒 . Then Eq. (19) is used to compute the values of 𝐺𝑒 . Then
rank alternatives according to ascending values of 𝐺𝑒 . 𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀2 ≻ 𝐴𝐶𝑀4. Fig
3 shows the rank of alternatives by the VIKOR method.

0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
ACM1

ACM2

ACM3

ACM4

Values
Fig 3. Rank of alternatives by the VIKOR method.

Table 4. The positive and cost ideal solution by the VIKOR method.
Criteria/alternatives

𝑨𝑳𝑴𝟏

𝑨𝑳𝑴𝟐

𝑨𝑳𝑴𝟑

𝑨𝑳𝑴𝟒

𝑨𝑳𝑴𝟓

𝐴𝐶𝑀1

0

0.13279

0

0

0.301744

𝐴𝐶𝑀2

0.138656

0

0.168678

0.227536

0.245238

𝐴𝐶𝑀3

0

0.163386

0.168678

0.190658

0

𝐴𝐶𝑀4

0.018652

0

0.168678

0.190658

0.301744

4. Comparative analysis
In this section, we compare our methods (SVNNs TOPSIS and VIKOR) with Bipolar
Neutrosophic Numbers (BNNs VIKOR and TOPSIS) [47] to show the validity of our
proposed model. We used the same weights. Fig 4. Show the rank of alternatives under four
methods. Table 5 shows the best and worst alternatives. All four methods show the 𝐴𝐶𝑀3
is the best alternative. The SVNNs TOPSIS show 𝐴𝐶𝑀2 is the worst alternative and other
three methods show 𝐴𝐶𝑀4 is the worst alternative. Table 5 show the correlation between
four methods. The correlation between the four methods is strong.
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4.5
4
3.5
3
2.5
2

1.5
1
0.5
0
ACM1

ACM2

ACM3

ACM4

SVNNs TOPSIS

SVNNs VIKOR

BNNs TOPSIS

BNNS VIKOR

Fig 4. The rank of alternative under comparative analysis.

Table 5. The rank of alternatives by the four methods.
𝑹𝒂𝒏𝒌

Methods

SVNNs TOPSIS 𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀4 ≻ 𝐴𝐶𝑀2
SVNNs VIKOR

𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀2 ≻ 𝐴𝐶𝑀4

BNNs TOPSIS

𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀2 ≻ 𝐴𝐶𝑀4

BNNS VIKOR

𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀2 ≻ 𝐴𝐶𝑀4

Table 6. Pearson correlation between methods.
Methods

Correlation

SVNNs TOPSIS and SVNNs VIKOR

0.8

SVNNs TOPSIS and BNNs TOPSIS

0.8

SVNNs TOPSIS and BNNs VIKOR

0.8

SVNNs VIKOR and BNNs TOPSIS

1

SVNNs VIKOR and BNNs VIKOR

1
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5. Sensitivity Analysis
In this section, we change the weights of criteria and then compute the rank of
alternatives. Table 7 shows the five cases in changing weights of criteria. In Fig 5. The
weights of criteria under five cases. In each case we put the weight by 0.5 and the rest of 0.5
is disrupted to all other criteria. For example, in case 1, the first criteria is 0.5 and the other
criteria have 0.125 weights. Fig 6. Show the rank of alternatives under five cases by the
TOPSIS method. Fig 7. Show the rank of alternatives under five cases by the VIKOR method.
Table 8 and Table 9. Show the rank of alternatives by the TOPSIS and VIKOR methods under
five cases. In case 1, we put the first criteria with 0.5 weight and the other four criteria have
0.125. In case 2, the second criteria have 0.5 and the other four criteria have 0.125. In case 3,
the third criteria have 0.5 and the other four criteria have 0.125. In case 4, the fourth criteria
has 0.5 and the other four criteria have 0.125. In case 5, the fifth criteria have 0.5 and the
other four criteria have 0.125.
Table 7. The five cases change the weights of the criteria.
Criteria

Case 1

Case 2

Case 3

Case 4

Case 5

𝐴𝐿𝑀1

0.5

0.125

0.125

0.125

0.125

𝐴𝐿𝑀2

0.125

0.5

0.125

0.215

0.125

𝐴𝐿𝑀3

0.125

0.125

0.5

0.125

0.125

𝐴𝐿𝑀4

0.125

0.125

0.125

0.5

0.125

𝐴𝐿𝑀5

0.125

0.125

0.125

0.125

0.5
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Case 2

Case 3
ALM1
0.5
0.4
0.3
0.2
0.1
0

ALM5

ALM4

Case 4

Case 5

ALM2

ALM3

Fig 5. The weights of criteria under five cases.
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Fig 6. The rank of the TOPSIS method under five cases.
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Fig 7. The rank of the VIKOR method is under five cases.

Table 8. The rank of alternatives by the TOPSIS method under five cases.
Cases

𝐑𝐚𝐧𝐤 by the TOPSIS method

Case 1 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀4 ≻ 𝐴𝐶𝑀2
Case 2 𝐴𝐶𝑀4 ≻ 𝐴𝐶𝑀2 ≻ 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀3
Case 3 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀4 ≻ 𝐴𝐶𝑀2
Case 4 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀4 ≻ 𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀2
Case 5 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀2 ≻ 𝐴𝐶𝑀4

Table 9. The rank of alternatives by the VIKOR method under five cases.
Cases

𝐑𝐚𝐧𝐤 by the TOPSIS method

Case 1 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀4 ≻ 𝐴𝐶𝑀2
Case 2 𝐴𝐶𝑀4 ≻ 𝐴𝐶𝑀2 ≻ 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀3
Case 3 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀4 ≻ 𝐴𝐶𝑀2
Case 4 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀4 ≻ 𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀2
Case 5 𝐴𝐶𝑀3 ≻ 𝐴𝐶𝑀1 ≻ 𝐴𝐶𝑀2 ≻ 𝐴𝐶𝑀4
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6. Conclusions
According to the results of this study, a new method to prioritize acute leukemia based on
their weight is proposed. Neutrosophic AHP and neutrosophic TOPSIS and VIKOR are used
in the suggested approach to rank alternatives in acute leukemia. Because the relationships
between acute leukemia data are likewise represented using neutrosophic numbers, the
integration of all these components is also carried out using neutrosophic operations.
This methodology can be employed in future research on any other MCDM problems.
Furthermore, additional forms of fuzzy sets, such as intuitionistic, hesitant, and
Pythagorean fuzzy sets, which reflect uncertainty in different ways, can be added to this
strategy. The use of many decision-making methodologies, such as multi-criteria decisionmaking, can also be used for acute leukemia.
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